Please Wait.....
Report
Small Scale Bioreactors Market Report and Forecast 2025-2034
Market Report I 2025-07-29 I 350 Pages I EMR Inc.
The global small scale bioreactors market size was valued at USD 2.00 Billion in 2024 , driven by the increasing prevalence of chronic diseases such as cancer across the globe. The market size is anticipated to grow at a CAGR of 14.30% during the forecast period of 2025-2034 to achieve a value of USD 7.61 Billion by 2034 .
Small Scale Bioreactors: Introduction
Small scale bioreactors are containers specialized to be used for cultivating microorganisms or living cells under accurately controlled conditions, facilitating the production of various molecules. These bioreactors are particularly valuable as essential tools for process development and optimization in pharmaceutical and biopharmaceutical studies. Typically designed for smaller-scale production, they come in a range of sizes, spanning from a few millilitres to 5-10 litres. Notably, small scale bioreactors offer economic advantages, requiring less labour than their larger counterparts.
These bioreactors are often employed as cost-effective miniaturized alternatives that effectively replicate almost all the functional capabilities of bench-scale reactors at significantly reduced volumes. Small Scale bioreactors have the capability for parallel operation enabling a cost-efficient series of experiments to be conducted. A few examples of small scale bioreactors include shake flasks, microtiter plates, and benchtop bioreactors. Additionally, small scale bioreactors come in both reusable and single-use variants, with the latter employing disposable bags in lieu of traditional reusable steel vessels.
Global Small Scale Bioreactors Market Analysis
The global market for small scale bioreactors is witnessing notable trends that are shaping its trajectory in recent years and are expected to continue in the forecast period. One significant trend is the substantial surge in sales of small scale bioreactors in 2020 and 2021, primarily driven by numerous businesses expanding their facilities to conduct crucial research and development for COVID-19 vaccines. This heightened demand for bioprocessing equipment played a pivotal role in the market's growth. Furthermore, with ongoing global immunization campaigns and the persistent demand for vaccines, the sales of small scale bioreactors are expected to maintain their upward trajectory.
Government authorities have also made substantial investments in enhancing biopharmaceutical research and expediting vaccine development, further influencing the Small Scale bioreactors market growth. These investments are geared towards advancing the capabilities of bioprocessing equipment, including small scale bioreactors, to meet the increasing demands for vaccine production and other biopharmaceutical research needs. As a result, the small scale bioreactors market is expected to continue to thrive, driven by these trends that underscore the critical role of bioprocessing in addressing global healthcare challenges.
Global Small Scale Bioreactors Market Segmentations
Small Scale Bioreactors Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
- Reusable Bioreactors
??- Stainless Steel Bioreactors
??- Glass Bioreactors
- Single-Use Bioreactors
Market Breakup by Capacity
- 5 mL-100 mL
- 100 mL - 250 mL
- 250 mL - 500 mL
- 500 mL - 1 L
- 1 L - 3 L
- 3 L - 5 L
Market Breakup by Cells
- Bacterial Cells
- Yeast Cells
- Mammalian Cells
Market Breakup by End User
- Pharmaceutical and Biopharmaceutical Companies
- CROs and CMOs
- Academic and Research Institutes
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Small Scale Bioreactors Market Overview
The global market for small scale bioreactors is experiencing robust growth driven by key factors such as the widespread utilization of small scale bioreactors in the pharmaceutical industry, coupled with the expansion of product portfolios by key players, which has significantly contributed to market expansion. These bioprocessing tools play a crucial role in the development and optimization of processes, making them invaluable in pharmaceutical and biopharmaceutical research. Small scale bioreactors typically range in size from a few millilitres to 5-10 litres and are essential for small scale production.
The increasing prevalence of chronic diseases such as cancer, cardiac disease, diabetes, and hypertension has also driven the development of innovative biological therapies, contributing to the increased demand for small scale bioreactors, particularly for producing monoclonal antibodies and personalized medicines. The adoption of advanced technologies to streamline complex manufacturing processes is also boosting the demand for Small Scale bioreactors in the biopharmaceutical sector, further propelling the small scale bioreactors market growth.
Moreover, significant investments in research and development activities by key biopharmaceutical companies are expected to further propel industry growth. The rising investments in biopharmaceutical research, driven by the growing incidence of chronic diseases and the demand for novel biologic drugs, coupled with the adoption of advanced bioprocessing equipment like small scale bioreactors, are some of the key drivers fuelling the growth of the market.
Global Small Scale Bioreactors Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Sartorius AG
- Merck KGaA
- Lonza Group
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Getinge AB
- Eppendorf AG
- Miltenyi Biotec
- Solaris Biotechnology Srl
- Infors AG
- H.E.L Group
- Lianyungang Bailun Biochemical Technology Co., Ltd
- Cytiva
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Small Scale Bioreactors Market Overview
3.1 Global Small Scale Bioreactors Market Historical Value (2018-2024)
3.2 Global Small Scale Bioreactors Market Forecast Value (2025-2034)
4 Global Small Scale Bioreactors Market Landscape
4.1 Global Small Scale Bioreactors Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Small Scale Bioreactors Product Landscape
4.2.1 Analysis by Type of Biosensor
4.2.2 Analysis by Technology Used
4.2.3 Analysis by Applications
5 Global Small Scale Bioreactors Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter's Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Small Scale Bioreactors Market Segmentation
6.1 Global Small Scale Bioreactors Market by Product
6.1.1 Market Overview
6.1.2 Reusable Bioreactors
6.1.2.1 Stainless Steel Bioreactors
6.1.2.2 Glass Bioreactors
6.1.3 Single Use Bioreactors
6.2 Global Small Scale Bioreactors Market by Capacity
6.2.1 Market Overview
6.2.2 5 mL-100 mL
6.2.3 100 mL - 250 mL
6.2.4 250 mL - 500 mL
6.2.5 500 mL - 1 L
6.2.6 1 L - 3 L
6.2.7 3 L - 5 L
6.3 Global Small Scale Bioreactors Market by Cells
6.3.1 Market Overview
6.3.2 Bacterial Cells
6.3.3 Yeast Cells
6.3.4 Mammalian Cells
6.4 Global Small Scale Bioreactors Market by End User
6.4.1 Market Overview
6.4.2 Pharmaceutical and Biopharmaceutical Companies
6.4.3 CROs and CMOs
6.4.4 Academic and Research Institutes
6.4.5 Others
6.5 Global Small Scale Bioreactors Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Small Scale Bioreactors Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Small Scale Bioreactors Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Small Scale Bioreactors Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Small Scale Bioreactors Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Small Scale Bioreactors Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Sartorius AG
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Merck KGaA
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Lonza Group
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Thermo Fisher Scientific Inc.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Danaher Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Getinge AB
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Eppendorf AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Miltenyi Biotec
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Solaris Biotechnology Srl
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Infors AG
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 H.E.L Group
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Lianyungang Bailun Biochemical Technology Co., Ltd
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Cytiva
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Small Scale Bioreactors Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security